Health Care Inc.: MAGA backs Medicare, faux drug price transparency
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Medicare Savings Programs face cut, hospitals and insurers report Q2 results
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Sarepta Therapeutics’ Elevidys faces ‘arduous’ path back to market
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
GSK’s blood cancer drug Blenrep hits setback with FDA advisers
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
FDA focuses attention on rejected drug decisions
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…